BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 10209153)

  • 1. Apoptosis control by death and decoy receptors.
    Ashkenazi A; Dixit VM
    Curr Opin Cell Biol; 1999 Apr; 11(2):255-60. PubMed ID: 10209153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
    Ibrahim SM; Ringel J; Schmidt C; Ringel B; Müller P; Koczan D; Thiesen HJ; Löhr M
    Pancreas; 2001 Jul; 23(1):72-9. PubMed ID: 11451151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.
    Inman GJ; Allday MJ
    J Immunol; 2000 Sep; 165(5):2500-10. PubMed ID: 10946276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuning the rheostat of the myelopoietic system via Fas and TRAIL.
    Greil R; Anether G; Johrer K; Tinhofer I
    Crit Rev Immunol; 2003; 23(4):301-22. PubMed ID: 14700272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus.
    Washburn B; Weigand MA; Grosse-Wilde A; Janke M; Stahl H; Rieser E; Sprick MR; Schirrmacher V; Walczak H
    J Immunol; 2003 Feb; 170(4):1814-21. PubMed ID: 12574346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
    Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A
    Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kiss of death: promises and failures of death receptors and ligands in cancer therapy.
    Daniel PT; Wieder T; Sturm I; Schulze-Osthoff K
    Leukemia; 2001 Jul; 15(7):1022-32. PubMed ID: 11455969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modular nature of apoptotic signaling proteins.
    Hofmann K
    Cell Mol Life Sci; 1999 Jul; 55(8-9):1113-28. PubMed ID: 10442092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Fas ligand-induced apoptosis by TNF.
    Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
    J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1.
    Sheikh MS; Antinore MJ; Huang Y; Fornace AJ
    Oncogene; 1998 Nov; 17(20):2555-63. PubMed ID: 9840918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis.
    Velthuis JH; Rouschop KM; De Bont HJ; Mulder GJ; Nagelkerke JF
    J Biol Chem; 2002 Jul; 277(27):24631-7. PubMed ID: 11980895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live and let die: regulatory mechanisms in Fas-mediated apoptosis.
    Curtin JF; Cotter TG
    Cell Signal; 2003 Nov; 15(11):983-92. PubMed ID: 14499341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
    Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
    J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.
    Seino K; Setoguchi Y; Ogino T; Kayagaki N; Akiba H; Nakano H; Taniguchi H; Takada Y; Yuzawa K; Todoroki T; Fukuchi Y; Yagita H; Okumura K; Fukao K
    Ann Surg; 2001 Nov; 234(5):681-8. PubMed ID: 11685033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL: a molecule with multiple receptors and control mechanisms.
    Griffith TS; Lynch DH
    Curr Opin Immunol; 1998 Oct; 10(5):559-63. PubMed ID: 9794836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles.
    Schneider-Brachert W; Tchikov V; Neumeyer J; Jakob M; Winoto-Morbach S; Held-Feindt J; Heinrich M; Merkel O; Ehrenschwender M; Adam D; Mentlein R; Kabelitz D; Schütze S
    Immunity; 2004 Sep; 21(3):415-28. PubMed ID: 15357952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antagonist decoy receptor and a death domain-containing receptor for TRAIL.
    Pan G; Ni J; Wei YF; Yu G; Gentz R; Dixit VM
    Science; 1997 Aug; 277(5327):815-8. PubMed ID: 9242610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death receptor-induced cell killing.
    Thorburn A
    Cell Signal; 2004 Feb; 16(2):139-44. PubMed ID: 14636884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.